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© 2011 The Japan Society of Histochemistry and Cy- We developed a novel ultrarapid immunohistochemical staining method in which an AC
electric field is used to facilitate detection of tumor cells. Frozen sections of non-small cell
lung cancer in lymph nodes were fixed in acetone for 2 min, after which they were incubated
for 2 min with an anti-pancytokeratin antibody cocktail and then with EnVisionTM complex
under an alternating current (AC) electric field. The sections were then incubated with a
chromogen (3,3'diaminobenzidine) for 3 min and counterstained with hematoxylin. This
method enabled detection of tumor cells in frozen sections in less than 15 min. In addition,
we were able to reduce the amount of antibody used by more than 90% when the sections
were incubated under the AC electric field for a longer period. This method could be a useful
tool for frozen section diagnosis and research. Furthermore, with this method the cost of
immunohistochemical staining can be reduced.
Key words: immunohistochemical staining, lymph node metastases, micrometastases
I. Introduction
Detection of single tumor cells or small tumor cell
clusters within lymph nodes and specimens from the sur-
gical margin of resected tissue is very important in intra-
operative frozen section analysis. In particular, micro-
metastases in lymph nodes sometimes cannot be detected
on the basis of hematoxylin and eosin (HE) staining alone,
but only after additional time-consuming immunohisto-
chemical (IHC) investigation of paraffin-embedded tissue.
This is noteworthy, as nodal micrometastasis is reportedly
associated with poorer survival rates than node-negative
disease in breast cancer [4, 22, 25] and non-small cell lung
cancer (NSCLC) [5, 10]. Recently, the sentinel node con-
cept was introduced into the surgical procedures for breast
cancer [15], malignant melanoma [2], gastric cancer [14]
and NSCLC [20]. The rapid, reliable and sensitive intra-
operative histopathological evaluation of distant sentinel
nodes represents a crucial element of successful applica-
tion of the sentinel node concept. However, Turner et al.
reported that 10 (14.3%) of 70 patients assessed as tumor-
free using routine HE staining were found to be sentinel
node-positive using IHC cytokeratin analysis [26]. Unfortu-
nately, although the sensitivity of IHC analysis using anti-
cytokeratin antibody is sufficient to detect micrometastasis,
the standard protocol requires 2–4 hours to complete. To
solve this problem, several investigators have proposed
rapid methods that enable IHC protocols to be accom-
plished within only 12 to 30 min [6, 7, 12, 13, 16–19, 23].
In addition, we have developed a rapid method for detect-
ing cytokeratin-positive tumor cells in lymph nodes using
flow cytometry [24], which enables us to detect lymph node
micrometastases within 40 min. None of these methods is
problem free, however. For example, our use of flow cytom-
etry was limited by the frequency of false-positives causedToda et al. 134
by the lack of morphological observation. To overcome that
limitation, we have now developed a device that enables
us to complete IHC analyses within 15 min using an
alternating current (AC) electric field (patent pending). The
aim of the present study was to evaluate the clinical signifi-
cance, reliability, and sensitivity of the novel ultrarapid IHC
method developed at our institute using this device.
II. Materials and Methods
Ten consecutive patients with NSCLC were enrolled
in the study between July 2010 and August 2010 after
obtaining signed informed consent. Surgically resected
specimens were used under approval of the Institutional
Review Boards at Akita University School of Medicine and
University Hospital. After a preoperative evaluation, the
patients were taken to an operating room, and the standard
preparations were made for a thoracotomy, lung resection,
and mediastinal lymph node dissection. Lymph nodes from
each patient were used for this study.
IHC procedures
Tissue preparation
Lymph nodes were surgically resected from patients
with NSCLC. Immediately after removal, the nodes were
embedded in O.C.T. compound (Sakura Finetek Japan Co.,
Ltd., Tokyo, Japan) and frozen for 30 sec in liquid acetone at
−80°C in Histo-Tek Pino (Sakura Finetek Japan Co., Ltd.,
Tokyo, Japan) and then transferred to a cryostat (CM1900
Leica, Wetzlar, Germany).
The device for IHC analysis (Fig. 1)
We have developed a device that reduces the time
required for IHC, as well as the amount of antibody required
for these analyses. With this device, we can apply a high-
voltage, low-frequency AC electric field to the sections. The
resultant coulomb force stirs the antibody solution on the
sections. To examine the mixing effect of the device, the AC
electric field was also applied to ferrite particles (average
diameter: 50 nm) in PBS. To prevent evaporation of the
antibody solution, the device was equipped with a humidi-
fier, and all incubations were carried out under a humidified
atmosphere. With the humidifier, the amount of antibody
solution remained unchanged, even after 3 hr of incubation.
Rapid AC electric IHC procedure (Table 1)
Serial frozen sections were cut at 5 μm and placed on
slides, air-dried for 30 sec, fixed in acetone for 2 min at
room temperature, air-dried for 15 sec at room temperature,
and subjected to the staining procedure. No attempt was
made to block endogenous peroxidase. For staining, the sec-
tions were incubated for 2 min with a monoclonal mouse
Fig. 1. New device for AC electric field IHC. Panel A depicts a schematic diagram of a device for AC electric field IHC analysis. Panel B
depicts a typical oscilloscope trace of the voltage and frequency of the AC electric field. A high voltage (3.4 kV, offset 2.4 kV), low frequency
(18 Hz) AC electric field was applied to the sections. Panels 1C and 1D show the device, which was equipped with a humidifier to prevent
evaporation of the antibody solution. To visualize the mixing effect of the device, the AC electric field was also applied to ferrite particles
(average diameter: 50 nm) in PBS. Note that the brown particles (red arrows) were unevenly distributed at 1 and 4 sec, but were well mixed
and homogeneously distributed within 9 sec (Panel E). I.T.O. electrode, indium tin oxide glass plate electrode; ab, antibody.Ultrarapid IHC to Detect Micrometastases 135
anti-pancytokeratin antibody cocktail (AE1/AE3; PROGEN
Biotechnik GmbH, Heidelberg, Germany) at 1:200 dilution
(5 μg/mL) under a high-voltage (3.4 kV, offset 2.4 kV),
low-frequency (18 Hz) AC electric field. The sections
were then washed with PBS and incubated for 2 min with
EnVisionTM+ System/HRP Mouse (DAB+) (Dako) under
the same AC electric field. After again washing with PBS,
the sections were developed with 3,3'diaminobenzidine sub-
strate, counterstained with hematoxylin, dehydrated, and
mounted on coverslips.
Standard IHC procedure (Table 1)
Serial frozen sections were cut at 5 μm and placed
on slides, air-dried for 30 sec, fixed in acetone for 10 min
at 4°C, air-dried for 15 sec at room temperature, and
subjected to the staining procedure. No attempt was made
to block endogenous peroxidase. For staining, the sections
were first incubated for 60 min with AE1/AE3 at 1:200
dilution (5 μg/mL). They were then washed with PBS,
incubated for 30 min with EnVisionTM+ System/HRP
Mouse (DAB+), washed again with PBS, developed with
3,3'diaminobenzidine substrate, counterstained with hemato-
xylin, dehydrated, and mounted on coverslips.
Saving AC electric IHC procedure (Table 1)
Serial frozen sections were cut at 5 μm and placed on
slides, air-dried for 30 sec, fixed in acetone for 2 min at room
temperature, air-dried for 15 sec at room temperature, and
subjected to the staining procedure. No attempt was made to
block endogenous peroxidase. For staining, sections were
incubated for 60–180 min with AE1/AE3 at 1:500–2,000
dilution (0.5–2.0 μg/mL) under a high voltage (3.4 kV,
offset 2.4 kV), low frequency (18 Hz) AC electric field.
The sections were then washed with PBS and incubated
for 2 min with EnVisionTM+ System/HRP Mouse (DAB+)
(Dako) under the same AC electric field. After washing
again with PBS, the sections were developed with 3,3'diami-
nobenzidine substrate, counterstained with hematoxylin,
dehydrated, and mounted on coverslips.
III. Results
We initially visualized the mixing effect of our device
by applying the high voltage (3.4 kV), low frequency
(18 Hz) AC electric field used for IHC analysis to ferrite
particles in PBS. We observed that the ferrite particles
were well mixed within 9 sec (Fig. 1E).
We then stained metastatic NSCLC cells in lymph
nodes with an anti-pancytokeratin antibody cocktail, AE1/
AE3, using standard IHC procedures or rapid AC electric
or saving AC electric IHC procedures. Tumor cells within
lymph nodes were stained equally well using the rapid AC
electric procedure or the standard IHC procedure. Moreover,
when the AC electric field was applied to sections for 60
min, the concentration of AE1/AE3 could be diluted 1:500,
and when the AC electric field was applied for 180 min, the
AE1/AE3 could be diluted 1:2,000. Without the AC electric
field, the sections were not stained with AE1/AE3 at this
dilution. Figure 2 depicts typical images obtained using
the standard, rapid AC electric, and saving AC electric IHC
procedures (dilution 1:2,000, 180 min AC electric field),
respectively.
An essential purpose of IHC analysis during surgery
for NSCLC is detection of sentinel node micrometastasis
without misdiagnosis. This means that to apply the rapid AC
electric field IHC procedure in practice, its ability to detect
micrometastases must be at least equal to that of the standard
IHC procedure. Therefore, to further determine the effec-
Table 1. Procedures and time for immunohistochemical staining
Routine IHC procedure Saving AC electric IHC procedure Rapid AC electric IHC procedure
Acetone fixation 4°C
10 min
Room temperature
2 min
Room temperature
2 min
Washing with PBS 5 min
3 times
30 sec
once
30 sec
once
Primary antibody w/o AC electric field
60 min
AC electric field
60–180 min
AC electric field
2 min
Concentration of primary antibody 5.0 µg/mL
(1:200)
0.5–2.0 µg/mL
(1:500–2,000)
5.0 µg/mL
(1:200)
Washing with PBS 5 min
3 times
30 sec
once
30 sec
once
EnVisionTM+ System/HRP Mouse w/o AC electric field
30 min
AC electric field
2 min
AC electric field
2 min
Washing with PBS 5 min
3 times
30 sec
once
30 sec
once
3,3'diaminobenzidine 3 min 3 min 3 min
Approximate time required 148 min 69–189 min 11 minToda et al. 136
tiveness of the AC electric field on the rapid IHC procedure,
we compared the abilities of the standard and rapid AC
electric field IHC procedures to detect lymph node micro-
metastases. Typical images of lymph node micrometastasis
obtained using the rapid AC electric field IHC procedure are
shown in Figure 3. Endogenous peroxidase-positive granulo-
cytes were also observed around cytokeratin-positive cancer
cell nests. However, the cancer cells could be distinguished
from endogenous peroxidase-positive leukocytes based on
their morphology. Therefore, to shorten the staining period,
we did not use endogenous peroxidase blockage in the
present study. Note that the lymph node micrometastases
detected using the standard IHC procedure were always
detectable using the rapid AC electric field IHC procedure.
Fig. 2. Pancytokeratin immunoreactivity toward metastatic NSCLC cells in a lymph node. The tissue sections were stained with anti-
pancytokeratin antibody (AE1/AE3) using standard IHC (panel A), negative control for standard IHC (panel B), rapid AC electric field IHC
(panel C), negative control for rapid AC electric field IHC (panel D), saving AC electric field IHC (dilution 1:2,000, 180 min AC electric field)
(panel E), saving AC electric field IHC (panel F) procedures. Bar=100 µm.Ultrarapid IHC to Detect Micrometastases 137
IV. Discussion
In the present study we demonstrated that tumor cells
in lymph nodes can be detected within 11 min under a
high voltage, low frequency AC electric field using the
device developed at our institute. Furthermore, not only does
this method enable rapid IHC staining, it can also potentially
reduce the cost of the IHC procedure.
Conventional analysis of frozen tissue sections using
HE staining enables diagnosis within 20 min at most
institutions [27], but the sensitivity of this method for
detecting micrometastases is comparatively low. By con-
trast, the sensitivity of IHC analysis using anti-cytokeratin
antibody is sufficient to detect micrometastasis, but the
standard IHC procedure commonly requires 2–4 hr to com-
plete. To address this issue, several investigators proposed
rapid methods that enable the IHC procedure to be accom-
plished within only 12 to 30 min [6, 7, 13, 16–18, 23, 24,
27]; however, these methods are not problem-free. For
example, the new EnVisionTM system has been described as
a very sensitive and rapid detection system for IHC [24,
27], and Kämmerer et al. and Mönig et al. reduced the
time for immunostaining of frozen sections to less than 13
min using the EnVision system. To do so, however, they
applied a higher concentration of primary antibody than is
used for standard IHC [13, 17]. By contrast, our ultrarapid
AC electric field IHC procedure required about the same
amount of time as the EnVisionTM system, and we were
able to use the same concentration of primary antibody
used in the standard IHC procedure. Given the expense of
primary antibodies, we believe this represents a significant
advantage over other procedures. It is also known that
microwave irradiation shortens IHC times. Hatta et al.
reported that IHC could be completed within 15 min using
an intermittent microwave irradiation method in combina-
tion with a prepared immune complex consisting of the
primary antibody, secondary antibody and EnVisionTM-
solution [11]. The utility of our AC electric field method
is comparable to this microwave approach.
The cost of IHC analysis is high because primary
antibodies are expensive. Therefore, reducing the amount
of primary antibody needed for IHC can have a significant
impact on cost. In particular, diagnosis of lymph node
micrometastasis requires the use of step sections of the
lymph nodes in question. According to the 6th edition of
cancer staging manual of the American Joint Committee on
Cancer, micrometastases are defined as being >0.2 mm but
≤2.0 mm in diameter [9]. Consequently, step sections must
be collected every 0.2 mm so as not to miss any tumor
tissue. In an effort to reduce the amount of primary antibody
needed, we applied the AC electric field IHC procedure. We
found that when the AC electric field was applied to sections
for 180 min, the concentration of primary antibody could be
reduced by more than 90%.
The mechanism by which our method promotes the
antigen-antibody reaction is not fully understood. In this
study we applied a high voltage (3.4 kV, offset 2.4 kV),
low frequency (18 Hz) AC electric field to IHC. Before
we adopted this approach, we tested a variety of other
methods for stirring small amounts of solution, ultimately
determining that application of an AC electric field worked
best under our conditions. It is known that when an AC
electric field is applied to a solution, electro-osmotic
vortices are produced [3], which were used by Wang et
al. [28] to induce non-contact mixing. However, we do not
believe such vortices are responsible for the enhanced
antigen-antibody reaction seen in the present study. We
previously showed that an interaction force affecting a
droplet can be generated as a coulomb force applied from
an AC electric field [1]. The generated force reflects the
difference between dielectric constants and the electric
conductivity. In particular, when a droplet is attracted to
Fig. 3. Detection of micrometastasis using the rapid AC electric
field IHC procedures. To confirm the ability of the rapid AC elec-
tric field IHC procedure to detect lymph node micrometastasis, we
immunohistochemically stained lymph nodes positive for NSCLC
micrometastasis with anti-pancytokeratin antibody (AE1/AE3).
Panels A and B show low and high magnification images using the
rapid AC electric field IHC procedures, respectively. Endogenous
peroxidase-positive granulocytes were often observed. However,
cytokeratin-positive cancer cell nests could be readily discerned
based on their morphology. Bars=1,000 µm (panel A), 500 µm
(panel B).Toda et al. 138
the upper electrode by giving the electric field a positive
polarity, a wave is generated, and the stirring phenomenon is
caused by changes in the surface of this wave. We speculate
that this stirring promotes the antigen-antibody reaction.
Although the main purpose of the ultra-rapid IHC is
the diagnosis of sentinel node micrometastasis during the
surgery, avoiding axillary lymph node dissection based on
the results of sentinel node biopsy is now controversial in
breast cancer. Recently, the American College of Surgeons
Oncology Group Z0011 trial demonstrated that, among
patients with limited sentinel node metastatic breast cancer,
the use of sentinel node dissection alone did not result in
inferior survival, as compared to axillary lymph node dissec-
tion [8]. This result indicates that intraoperative diagnosis
of sentinel node micrometastasis may not be required, at
least in breast cancer. We speculate that the reason for this
is that radiation, chemotherapy, and endocrine therapy are
more effective with breast cancer than with cancers in other
organs. Unfortunately, radiation and chemotherapy are not
particularly effective in NSCLC. In addition, Ou and Zell
demonstrated that the number of lymph nodes removed at
surgery in patients without apparent lymph node metastasis
is a significant prognostic factor in NSCLC [21]. Further-
more, mediastinal lymph node dissection is still the standard
surgical procedure for patients with NSCLC. Therefore,
lymph node micrometastasis should not be ignored when
applying sentinel node mapping to NSCLC.
In conclusion, we were able to demonstrate the useful-
ness of our new method of AC electric field IHC analysis.
However, the method was only tested using a single anti-
body in a limited number of experiments. Further investiga-
tion using other antibodies in larger clinical studies will
be needed to confirm the utility of this method.
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